Trial intelligence / Profile preview

Prilosec OTC vs Zegerid for Gastric Acid Suppression

NCT00808769Phase 4Completed

Sponsor
Procter & Gamble
Start
Nov 2008
Primary completion
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of omeprazole in gastroesophageal reflux disease (GERD), sponsored by Procter & Gamble. Started Nov 2008; status: completed.

02

Drugs

omeprazole
03

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on NCT00808769.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00808769.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call